Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. [electronic resource]
Producer: 19990625Description: 97-102 p. digitalISSN:- 0006-291X
- Activins
- Animals
- Bone Development -- drug effects
- Bone Marrow Cells
- Bone Morphogenetic Protein 2
- Bone Morphogenetic Proteins -- pharmacology
- Carrier Proteins -- metabolism
- Cyclooxygenase 2
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors -- pharmacology
- Gene Expression Regulation, Developmental
- Indomethacin -- pharmacology
- Inhibins -- pharmacology
- Interleukin-1 -- pharmacology
- Isoenzymes -- metabolism
- Membrane Glycoproteins -- metabolism
- Mice
- Mice, Inbred Strains
- Nitrobenzenes -- pharmacology
- Osteoclasts -- physiology
- Prostaglandin-Endoperoxide Synthases -- metabolism
- RANK Ligand
- RNA, Messenger -- metabolism
- Receptor Activator of Nuclear Factor-kappa B
- Sulfonamides -- pharmacology
- Transforming Growth Factor beta -- pharmacology
- Up-Regulation -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.